Cargando…
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents
Defects in genes involved in DNA damage repair (DDR) pathway are emerging as novel biomarkers and targets for new prostate cancer drug therapies. A previous report revealed an association between an exceptional response to cisplatin treatment and a somatic loss of heterozygosity (LOH) of FANCA in a...
Autores principales: | Wilkes, David C., Sailer, Verena, Xue, Hui, Cheng, Hongwei, Collins, Colin C., Gleave, Martin, Wang, Yuzhuo, Demichelis, Francesca, Beltran, Himisha, Rubin, Mark A., Rickman, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593159/ https://www.ncbi.nlm.nih.gov/pubmed/28864460 http://dx.doi.org/10.1101/mcs.a001487 |
Ejemplares similares
-
Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα
por: Oppezzo, Alessia, et al.
Publicado: (2023) -
Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant
por: Lach, Francis P., et al.
Publicado: (2020) -
Coregulation of FANCA and BRCA1 in human cells
por: Haitjema, Anneke, et al.
Publicado: (2014) -
Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report
por: Qian, Bing, et al.
Publicado: (2022) -
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study
por: Mateo, Joaquin, et al.
Publicado: (2018)